par
Barbara Kram, Editor | November 07, 2006
* Instrumentation/animal model: Paul Acton (Thomas Jefferson University, Philadelphia, Pa.) and Cheryl Marks (National Cancer Institute, Bethesda, Md., chair);
* Drug development: Eric D. Agdeppa (GE Healthcare, Piscataway, N.J.), Steven Bodovitz (BioPerspectives, San Francisco, Calif.), Chaitanya Divgi, (University of Pennsylvania Hospital, Philadelphia, Pa.; chair), Juri Gelovani, (M.D. Anderson Cancer Center, Houston, Texas) and Richard Pestell, Kimmel Cancer Center, Philadelphia, Pa.);
* Clinical issues: Steve Larson, (Memorial Sloan-Kettering Cancer Center, New York, N.Y., chair), P. David Mozley (Merck Research Laboratories, West Point, Pa.), Adrian Nunn (Bracco Research USA, Princeton, N.J.) and Albert Sinusas (Yale University, New Haven, Conn.); and
* Education: William Heetderks (National Institutes of Health, Bethesda, Md.) and Lalitha Shankar (National Cancer Institute, Bethesda, Md., chair).
Ad Statistics
Times Displayed: 19605
Times Visited: 366 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
To learn more, visit SNM's Web site at http://www.snm.org. Watch for "Shaping the Future" Industry Summit Examines Future Basic Research, Instrumentation, Drug Development, Clinical Issues and Educational Needs; Published Reports Coming in December Journal of Nuclear Medicine
Back to HCB News
